Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1988-06-06
1993-09-14
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
435212, 435219, 435226, 4352412, 4353201, 536 232, 524 9463, C12N 948, C12N 1558, C12P 2102, A61K 37547
Patent
active
052446760
ABSTRACT:
A modified t-PA having improved in vivo half-life is disclosed comprising in sequence a fibronectin finger-like domain F, a growth factor domain GF, a sequence of two K2 kringle regions and a serine protease region SP, wherein the first of said kringles is free of any glycosylation site and the second of said kringles has a single glycosylation site.
REFERENCES:
patent: 5149533 (1992-09-01), Mulvihill et al.
Harris, T. J. R., Protein Engineering, 1(6), pp. 449-458, 1987.
Gething, M. J. et al., EMBO Journal, 7(9): 2731-2740, 1988.
Pennica et al., Nature 301, 214-221 (1983).
Vehar, Bio/Technology 2(12), pp. 1051-1057 (1984).
Kagitani et al., FEBS Lett. 189(1), 145-149 (1985).
Zonneveld et al., Proc. Natl. Acad. Sci. USA 83, 4670-4 (1986).
Verheijen et al., The EMBO J. 5(13), 3525-3530 (1986).
Ehrlich et al., Fibrinolysis 1, 75-81 (1987).
Klausner, Bio/Technology 4, 706-711 (1986).
Klausner, Bio/Technology 5, 869-870 (1987).
Lau et al., Bio/Technology 5(9), 953-958 (1987).
Bell Leslie D.
Mayer Ernest J.
Palmier Mark O.
Tolunay H. Eser
Warren Thomas G.
Hill Jr. Robert J.
Meyer Scott J.
Monsanto Company
Porta Marianne
LandOfFree
Modified tissue plasminogen activator with modified glycosylatio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified tissue plasminogen activator with modified glycosylatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified tissue plasminogen activator with modified glycosylatio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2024881